RecruitingNot ApplicableNCT06431828

Remote Symptom Review in Patients With Implantable Diagnostic Holter

Efficiency of a Clinical Process Based on Remote Review of Symptoms in Patients With an Implantable Diagnostic Holter.

Sponsor

Andres Iñiguez Romo

Enrollment

60 participants

Start Date

Apr 22, 2024

Study Type

INTERVENTIONAL

Conditions

Atrial Fibrillation Arrythmia Syncope Bradycardia

Summary

To study the clinical and organizational benefit of implementing a methodology for monitoring patients receiving an implantable diagnostic BIOMONITOR III holter and successive models, consisting of remote review of alerts sent by the device via the HOME MONITORING remote monitoring platform and the transmission of relevant patient symptoms through the use of a specific application installable on the patient's phone. The efficiency of this methodology will be compared with a control group consisting of monitoring through the usual clinical practice of the hospital.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether patients with a small heart monitor implanted under their skin can report their symptoms remotely using a smartphone app, instead of coming into the clinic for every check-in. **You may be eligible if...** - You are over 18 years old - You are getting a small implantable heart monitor (subcutaneous Holter device) because of unexplained fainting (syncope) or a stroke where the cause was not found (cryptogenic stroke, to check for an irregular heartbeat called atrial fibrillation) - You agree to have a patient app installed on your phone to send symptom updates - You are able to use the smartphone app **You may NOT be eligible if...** - You are over 80 years old, or you are not able to use a smartphone app - Your life expectancy is less than 12 months for any reason Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.